4e Therapeutics, Inc. — Form D
4e Therapeutics, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-12. The offering totals $2.0M, of which $1.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-11-12
- Form: D
- Accession: 0001888582-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.9M
- Remaining: $105K
- Investors: 23
- Date of first sale: 2021-10-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-420829
Issuer
- Name: 4e Therapeutics, Inc.
- CIK: 0001888582
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3800 N. LAMAR BLVD, AUSTIN, TX, 78756
- Phone: 512-577-7779
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Thomas Craig Benson | Director | Austin, TX |
| Eric Craig Price | Director | Austin, TX |
| Joseph Craig Price | Director | Austin, TX |
| Theodore Craig Price | Director | Austin, TX |
| Thomas Craig Benson | Executive Officer | Austin, TX |
More